Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

Published Online: Apr 25, 2014

Page range: 163 - 172

Received: Oct 12, 2013

Accepted: Oct 23, 2013

DOI: https://doi.org/10.2478/raon-2013-0086

Keywords

mesothelioma, pemetrexed, polymorphism, folate pathway, toxicity

© by Vita Dolzan

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.